These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma. Masuzaki R; Shiina S; Tateishi R; Yoshida H; Goto E; Sugioka Y; Kondo Y; Goto T; Ikeda H; Omata M; Koike K J Gastroenterol Hepatol; 2011 Apr; 26(4):759-64. PubMed ID: 21054516 [TBL] [Abstract][Full Text] [Related]
3. Combination guidance of contrast-enhanced US and fusion imaging in radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on contrast-enhanced US/fusion imaging. Minami T; Minami Y; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Inoue T; Hagiwara S; Ueshima K; Nishida N; Kudo M Oncology; 2014; 87 Suppl 1():55-62. PubMed ID: 25427734 [TBL] [Abstract][Full Text] [Related]
4. Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography. Lee MW; Rhim H; Cha DI; Kim YJ; Choi D; Kim YS; Lim HK AJR Am J Roentgenol; 2012 Jun; 198(6):1438-44. PubMed ID: 22623560 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation of hepatocellular carcinoma by three-dimensional sonography with a perflubutane-based contrast agent. Numata K; Fukuda H; Ohto M; Itou R; Nozaki A; Kondou M; Morimoto M; Karasawa E; Tanaka K Eur J Radiol; 2010 Aug; 75(2):e67-75. PubMed ID: 20015603 [TBL] [Abstract][Full Text] [Related]
6. [The validity of radiofrequency ablation for hepatocellular carcinoma]. Yokoyama Y; Yamasaki T; Kurokawa F; Okita K Gan To Kagaku Ryoho; 2004 Dec; 31(13):2105-9. PubMed ID: 15628752 [TBL] [Abstract][Full Text] [Related]
7. Hypertonic saline-enhanced radiofrequency versus chemoembolization sequential radiofrequency in the treatment of large hepatocellular carcinoma. El-Kady NM; Esmat G; Mahmoud EH; Darweesh SK; Mahmoud SH; Elagawy WA Eur J Gastroenterol Hepatol; 2013 May; 25(5):628-33. PubMed ID: 23325283 [TBL] [Abstract][Full Text] [Related]
8. Ultrasonography fusion imaging system increases the chance of radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on conventional ultrasonography. Makino Y; Imai Y; Ohama H; Igura T; Kogita S; Sawai Y; Fukuda K; Takamura M; Ohashi H; Murakami T Oncology; 2013; 84 Suppl 1():44-50. PubMed ID: 23428858 [TBL] [Abstract][Full Text] [Related]
9. [Echo-guided radiofrequency percutaneous ablation of hepatocellular carcinoma in cirrhosis using a cooled needle]. Marone G; Francica G; D'Angelo V; Iodice G; Pastore P; Altamura G; Cusati B; Siani A Radiol Med; 1998 Jun; 95(6):624-9. PubMed ID: 9717546 [TBL] [Abstract][Full Text] [Related]
10. New contrast enhanced ultrasonography agent: impact of Sonazoid on radiofrequency ablation. Hiraoka A; Hiasa Y; Onji M; Michitaka K J Gastroenterol Hepatol; 2011 Apr; 26(4):616-8. PubMed ID: 21418298 [No Abstract] [Full Text] [Related]
11. Ultrasound-guided ablative therapy for hepatic malignancies : a comparison of the therapeutic effects of microwave and radiofrequency ablation. Zhang XG; Zhang ZL; Hu SY; Wang YL Acta Chir Belg; 2014; 114(1):40-5. PubMed ID: 24720137 [TBL] [Abstract][Full Text] [Related]
12. Microwave ablation assisted by a real-time virtual navigation system for hepatocellular carcinoma undetectable by conventional ultrasonography. Liu FY; Yu XL; Liang P; Cheng ZG; Han ZY; Dong BW; Zhang XH Eur J Radiol; 2012 Jul; 81(7):1455-9. PubMed ID: 21477961 [TBL] [Abstract][Full Text] [Related]
13. Recent Advances in the Image-Guided Tumor Ablation of Liver Malignancies: Radiofrequency Ablation with Multiple Electrodes, Real-Time Multimodality Fusion Imaging, and New Energy Sources. Lee DH; Lee JM Korean J Radiol; 2018; 19(4):545-559. PubMed ID: 29962861 [TBL] [Abstract][Full Text] [Related]
14. Needle electrode position assessed using three-dimensional ultrasonography and outcome of radiofrequency ablation in hepatocellular carcinoma. Toshikuni N; Takuma Y; Tomokuni J; Yamamoto H Hepatogastroenterology; 2013 May; 60(123):428-31. PubMed ID: 23186605 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of contrast-enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: comparison with dynamic CT. Inoue T; Kudo M; Hatanaka K; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Sakurai T; Ueshima K; Nishida N Oncology; 2013; 84 Suppl 1():51-7. PubMed ID: 23428859 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI. Minami Y; Nishida N; Kudo M World J Gastroenterol; 2014 Apr; 20(15):4160-6. PubMed ID: 24764654 [TBL] [Abstract][Full Text] [Related]
17. Coagulation areas produced by cool-tip radiofrequency ablation and microwave ablation using a device to decrease back-heating effects: a prospective pilot study. Di Vece F; Tombesi P; Ermili F; Maraldi C; Sartori S Cardiovasc Intervent Radiol; 2014 Jun; 37(3):723-9. PubMed ID: 24196263 [TBL] [Abstract][Full Text] [Related]
18. Imaging Features of Radiofrequency Ablation with Heat-Deployed Liposomal Doxorubicin in Hepatic Tumors. Hong CW; Chow L; Turkbey EB; Lencioni R; Libutti SK; Wood BJ Cardiovasc Intervent Radiol; 2016 Mar; 39(3):409-16. PubMed ID: 26228246 [TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced ultrasound improves real-time imaging of ablation region during radiofrequency ablation: preliminary results. Wiggermann P; Zuber-Jerger I; Zausig Y; Loss M; Scherer MN; Schreyer AG; Stroszczynski C; Jung EM Clin Hemorheol Microcirc; 2011; 49(1-4):43-54. PubMed ID: 22214677 [TBL] [Abstract][Full Text] [Related]
20. Percutaneous, non-operative radio frequency ablation for haemostasis of ruptured hepatocellular carcinoma. Manikam J; Mahadeva S; Goh KL; Abdullah BJ Hepatogastroenterology; 2009; 56(89):227-30. PubMed ID: 19453063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]